Insights:
Commercialising Digital Health in Australia

FY2023 Industry Sentiment Survey

Commercialising Digital Health in Australia: FY2023 Industry Sentiment Survey

The results of ANDHealth's FY2023 industry sentiment survey has revealed that a lack of digital health specialised investors and limited access to capital remain the most significant impediments to commercialising new health technologies in Australia.

The Australian market needs more options for digital health investment in order to support the future commercialisation of our best and brightest new technologies.

“The core issue from industry is that Australia lacks dedicated digital health investment options,” said Bronwyn Le Grice, Chief Executive Officer of ANDHealth.

“The top 5 commercialisation challenges for digital health companies are limited access to capital and investors with skills and experience specific to digital health, lack of dedicated grant programs, implementation and uptake issues, and difficulty in accessing customers.

“Digital health offers a unique blend of the scalability of tech and the impact of health. Addressing the lack of dedicated and skilled capital for these emerging companies will be transformational for the Australian economy.”

Key Takeaways from the FY2023 Industry Sentiment Survey

Join our
mailing list

Stay up to date on news, programs and events
* indicates required